We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
12451
PUT
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$12K ﹤0.01%
477
-330
-41% -$11.2K
CIIGW
12452
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$12K ﹤0.01%
95,693
-529,357
-85% -$129K
QUMU
12453
CALL
DELISTED
Qumu Corp.
QUMU
$12K ﹤0.01%
+15,200
New +$18.5K
IIIIW
12454
DELISTED
INSU Acquisition Corp. III Warrant
IIIIW
$12K ﹤0.01%
131,245
-285,431
-69% -$44.4K
SECO
12455
DELISTED
Secoo Holding Limited ADR
SECO
$12K ﹤0.01%
+5,440
New +$15.5K
MONDW
12456
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$12K ﹤0.01%
42,509
+500
+1% +$225
CEMI
12457
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$12K ﹤0.01%
18,700
-4,300
-19% -$2.86K
CEMI
12458
DELISTED
Chembio diagnostics, Inc.
CEMI
$12K ﹤0.01%
17,965
+7,323
+69% +$4.86K
IMH
12459
DELISTED
Impac Mortgage Holdings Inc.
IMH
$12K ﹤0.01%
21,231
+703
+3% +$499
EVGN icon
12460
PUT
Evogene
EVGN
$9.49M
$11K ﹤0.01%
1,480
-3,860
-72% -$37.7K
HEPS
12461
D-Market Electronic Services & Trading
HEPS
$997M
$11K ﹤0.01%
18,738
-201,592
-91% -$293K
HOFV
12462
PUT
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$11K ﹤0.01%
868
-127
-13% -$2.12K
IMCC
12463
IM Cannabis
IMCC
$1.1M
$11K ﹤0.01%
278
+60
+28% +$4.31K
JG
12464
CALL
Aurora Mobile
JG
$34.2M
$11K ﹤0.01%
510
-105
-17% -$2.13K
OLB icon
12465
OLB
OLB
$4.37M
$11K ﹤0.01%
+1,202
New +$15K
OTLK icon
12466
Outlook Therapeutics
OTLK
$141M
$11K ﹤0.01%
528
-3,196
-86% -$91.9K
SATLW icon
12467
Satellogic Inc Warrant
SATLW
$75.1M
$11K ﹤0.01%
23,724
-1,466
-6% -$1.29K
TISI icon
12468
CALL
Team
TISI
$101M
$11K ﹤0.01%
1,500
-400
-21% -$5.51K
ENG
12469
PUT
DELISTED
ENGlobal Corp
ENG
$11K ﹤0.01%
1,488
-2,125
-59% -$19.4K
NRACW
12470
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$11K ﹤0.01%
99,693
-25,031
-20% -$4.7K
ARDS
12471
CALL
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$11K ﹤0.01%
+10,400
New +$12.9K
QTT
12472
PUT
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$11K ﹤0.01%
+11,200
New +$12.5K
TMDI
12473
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$11K ﹤0.01%
21,986
-92,020
-81% -$45K
TMPMW
12474
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$11K ﹤0.01%
152,797
+641
+0.4% +$111
ADTX
12475
CALL
DELISTED
ADITXT INC
ADTX
0

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.